MIDAS - Meaningful Integration of Data, Analytics and Services
From 01-11-2016 to 28-02-2020
Description
The MIDAS consortium is a partnership involving health authorities in five EU countries and the U.S. and technical big data experts from research institutions, MNCs and SMEs. Managing big data for ‘health in all’ is a monumental challenge for policy makers. MIDAS is addressing this challenge by developing and delivering an integrated solution which will liberate knowledge from data silos and unify heterogeneous big data sources to provide evidence-based actionable information and transform the way care is provided.
Despite the urgent need and opportunity, the level of e-health deployment, to share medical data is very low. Indeed 52% of the hospitals do not share any medical information with external GPs electronically.
MIDAS will map, acquire, manage, model, process and exploit this heterogeneous health care, governmental and open data to provide an innovative world leading beyond state of the art solution which will inform risk stratification and long term policy-making decisions, demonstrating a positive impact across the EU and beyond.
MIDAS will:
• Provide a data mapping solution
• Use open, social media and citizen data for high level policy analysis
• Use technology to exploit the value of big data for actionable information
• Disseminate best practice on privacy by design, ethics and governance
• Make Europe a leader in e-health platforms
Policy makers, patients and citizens will be co-creators of the solutions, ensuring that these are user validated, feedback is integrated, results are actionable and knowledge created to show benefit across a range of epidemiology challenges. Major health challenges which will be addressed include: aging population, obesity and mental health. Stakeholders will work together to make Europe a leader in e-health solutions, stimulating new opportunities for industry in this innovative field.
Team
- Michaela Black, Coordinator (External)
- Dale Weston, Promoter (External)
- Paul Carlin, Promoter (External)
- Patrick O'Sullivan, Promoter (External)
- Iván Macía, Promoter (External)
- Jarmo PÄÄKKÖNEN, Promoter (External)
- Jon Miller, Promoter (External)
- Austin Tanney, Promoter (External)
- Risto Kaikkohen, Promoter (External)
- Marko Grobelnik, Promoter (External)
- Paul Davis, Promoter (External)
- Mark van Gils, Promoter (External)
- Roberto Bilbao, Promoter (External)
- Bart De Moor, Promotor
- Gorana Nikolic, Research Leader
- Gijs Van Pottelbergh, Team member (External)
- Elke Lammertyn, Team member (External)
- Marc Claesen, Team member
- Xi Shi, Team member
- Geert Goderis, Team member (External)
- Bert Vaes, Team member (External)
Financing
Funding: EU Funding - European Funding
Program/Grant Type: EU Other - Other
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.